A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

Clinical trial NCT05934331 · RECRUITING

Trial details

NCT number: NCT05934331
Sponsor: LaNova Medicines Zhejiang Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasms of Digestive Organs

Start date: 2023-07-27
Primary completion: 2026-07-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.